Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Tristan Manalac, Yesterday
While antibody titres against SARS-CoV-2 wane with time, the immune system is capable of producing memory B-cells that can last for at least 6 months after infection, suggesting that the body will be able to protect itself in the case of re-exposure, according to a new study.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.

Obesity portends worse outcomes in COVID-19, even for young adults

Pearl Toh
18 Dec 2020

Obesity, particularly the severe class, was associated with an increased risk of mechanical ventilation and death in patients hospitalized with COVID-19 — a risk that is even more profound among the younger age group, reveals data from the AHA COVID-19 CVD registry*. 

“Although the severity of COVID-19 and probability of hospitalization and death are generally many-fold lower in younger compared with older individuals, our findings confirm that the protection from younger age does not extend to class III obese individuals,” the researchers stated.

“Clear public health messaging is needed for younger obese individuals who may underestimate their risk of severe COVID-19,” said presenting author Dr Nicholas Hendren from the University of Texas Southwestern Medical Center in Dallas, Texas, US, during the AHA 2020 Scientific Sessions.

Among the 7,606 hospitalized COVID-19 patients with BMI data available, obesity — particularly class III obesity (≥40.0 kg/m2) — was over-represented in the registry in comparison to the general US population, indicating that severely obese people were more likely to be hospitalised with COVID-19. Notably, this was especially so among younger individuals aged ≤50 years. [Circulation 2020;doi:10.1161/CIRCULATIONAHA.120.051936]

Compared with patients of normal weight (18.5-24.9 kg/m2), those who were obese were significantly more likely to experience the composite primary outcome of in-hospital mechanical ventilation and/or death — with greater risk seen with increasing obesity severity (adjusted odds ratios [ORs], 1.28, 1.57, and 1.80 for class I, II, and III obesity, respectively).

Specifically, the association was driven by the component of mechanical ventilation, which occurred at significantly higher rates in patients who were overweight or obese (≥25 kg/m2) than those with normal weight, regardless of age.

The risk of death was also significantly greater in those with severe obesity (class III; adjusted hazard ratio, 1.26, 95 percent confidence interval [CI], 1.00–1.58), but not in those with lower class of obesity.

When stratified by age group, the researchers found a significant interaction between age and BMI, such that the association between obesity and the primary composite outcome or death was particularly prominent in the younger subgroup (aged ≤50 years).

In addition, obesity was also associated with a higher risk of venous thromboembolism and renal replacement therapy. There was, however, no association between obesity and major adverse cardiovascular events (MACE).

“The similar in-hospital rates of cardiac arrest, shock, and MACE, despite the much younger age of obese patients hospitalized with COVID-19, highlights that young age does not protect against the cardiovascular complications of obesity,” the researchers pointed out.

“These observations support clear public health messaging and rigorous adherence to COVID-19 prevention strategies in obese individuals of all ages,” Hendren highlighted. “Severely obese individuals (BMI ≥40 kg/m2) should be considered high risk for severe COVID-19 infection and may warrant prioritization for a COVID-19 vaccine.”

 

*American Heart Association’s COVID-19 cardiovascular disease registry

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Tristan Manalac, Yesterday
While antibody titres against SARS-CoV-2 wane with time, the immune system is capable of producing memory B-cells that can last for at least 6 months after infection, suggesting that the body will be able to protect itself in the case of re-exposure, according to a new study.
Jairia Dela Cruz, 5 days ago
Spending too much time sitting cannot be good for the body, and rising to one's feet breaks up such a behaviour and yields small, but meaningful, reductions in certain cardiovascular disease (CVD) risk factors, according to the results of a meta-analysis.